PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma
2016 · Journal of Hematology & Oncology · 281 citations
https://doi.org/10.1186/s13045-016-0341-7
H
Hua Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
1.1K
Citations
12
h-index
13
i10-index
Hua Wang is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors. The author has an h-index of 12, co-authored 44 publications.
ORCID: 0000-0002-9751-8847Papers by this author
worksTargeted Therapy of Central Nervous System Acute Lymphoblastic Leukemia with an Integrin α6-Targeted Self-Assembling Proapoptotic Nanopeptide
2023 · Engineering · 5 citations
https://doi.org/10.1016/j.eng.2023.11.012
Stigmasterol, a Major Component of Cornus Officinalis, Ameliorates Osteoporosis in Diabetes Mellitus Effects by Increasing Bone Mineral Density
2025 · Journal of Musculoskeletal and Neuronal Interactions · 2 citations
https://doi.org/10.22540/jmni-25-142
Treatment outcomes of zanubrutinib-based regimen in newly diagnosed patients with MYC/BCL2 double-expressor diffuse large B-cell lymphoma: a retrospective multicenter real-world study
2025 · Annals of Hematology · 0 citations
https://doi.org/10.1007/s00277-025-06669-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat